TheraRadar

Pharma Intelligence, Simplified

Company Portfolios →

Haisco Pharmaceutical Group Co., Ltd.

33 active trials across 10 therapeutic areas

33
Active Trials
10
Phase 1
17
Phase 2
5
Phase 3
10
Therapeutic Areas

Immunology

9 active / 14 total
Ulcerative Colitis
3 active
3 total since 2015
Ankylosing Spondylitis
3 active
3 total since 2015
Psoriasis
2 active
2 total since 2015
Lupus
1 active
1 total since 2015
Rheumatoid Arthritis
0 active
5 total since 2015

Respiratory

9 active / 11 total
COPD
4 active 1 Ph3
5 total since 2015
Idiopathic Pulmonary Fibrosis
2 active
2 total since 2015
Asthma
2 active
2 total since 2015
Cystic Fibrosis
1 active 1 Ph3
2 total since 2015

Oncology

6 active / 6 total
Solid Tumor (Advanced)
2 active
2 total since 2015
Non-Hodgkin Lymphoma
1 active
1 total since 2015
Brain Tumor
1 active
1 total since 2015
Prostate Cancer
1 active
1 total since 2015
NSCLC
1 active
1 total since 2015

Pain

3 active / 8 total
Neuropathic Pain
2 active 1 Ph3
5 total since 2015
Postoperative Pain
1 active 1 Ph3
3 total since 2015

Rare Disease

2 active / 5 total
Spinal Muscular Atrophy
2 active
5 total since 2015

Metabolic

0 active / 6 total
Type 2 Diabetes
0 active
4 total since 2015
NASH/NAFLD
0 active
1 total since 2015
Dyslipidemia
0 active
1 total since 2015

Renal

0 active / 1 total
Chronic Kidney Disease
0 active
1 total since 2015

Urology

0 active / 1 total
Erectile Dysfunction
0 active
1 total since 2015

Cardiovascular

0 active / 1 total
Myocardial Infarction
0 active
1 total since 2015

CNS

0 active / 1 total
Neuropathy
0 active
1 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)